Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-10

Clinical Trial Update: Stopping Maintenance Therapy in People With Multiple Myeloma in MRD-Negative Remission

View source ↗

Summary

A Memorial Sloan Kettering Cancer Center study is testing whether maintenance therapy can be stopped in patients with multiple myeloma who are MRD-negative in r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Plasma Cell Myeloma | Status: ACTIVE_NOT_RECRUITING